Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,738,064 papers from all fields of science
Search
Sign In
Create Free Account
pivalyloxymethyl butyrate
Known as:
Pivaloyloxymethyl butyrate
, Pivaloyloxymethylbutyrate
An acyloxyalkyl ester prodrug of butyric acid. Pivaloyloxymethylbutyrate inhibits histone deacetylase, resulting in cell differentiation, cell growth…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Narrower (2)
AN-9
Pivanex
Broader (1)
Butyrates
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Synergistic Effect of Endogenous and Exogenous Aldehydes on Doxorubicin Toxicity in Yeast
J. Miles
,
S. J. Sojourner
,
Aurellia M Whitmore
,
Devon Freeny
,
S. Darling-Reed
,
H. Flores-Rozas
BioMed Research International
2018
Corpus ID: 49667980
Anthracyclines are frequently used to treat many cancers including triple negative breast cancer, which is commonly observed in…
Expand
2007
2007
Activation of clinically used anthracyclines by the formaldehyde-releasing prodrug pivaloyloxymethyl butyrate
S. Cutts
,
L. P. Swift
,
+4 authors
D. Phillips
Molecular Cancer Therapeutics
2007
Corpus ID: 18017893
The anthracycline group of compounds is extensively used in current cancer chemotherapy regimens and is classified as…
Expand
2005
2005
Butyric acid and pivaloyloxymethyl butyrate, AN-9, a novel butyric acid derivative, induce apoptosis in HL-60 cells
Y. Zimra
,
L. Wasserman
,
L. Maron
,
M. Shaklai
,
A. Nudelman
,
A. Rephaeli
Journal of Cancer Research and Clinical Oncology
2005
Corpus ID: 20661669
A novel butyric acid derivative, pivaloyloxymethyl butyrate, AN-9, was previously shown to be a potent differentiating agent. AN…
Expand
2004
2004
Activity of pivaloyloxymethyl butyrate, a novel anticancer agent, on primary human tumor colony-forming units
L. Siu
,
D. V. Von Hoff
,
+5 authors
S. Eckhardt
Investigational new drugs
2004
Corpus ID: 8872582
The anti-proliferative effects of pivaloyloxymethyl butyrate (AN-9), a butyric acid (BA) derivative with potent tumor…
Expand
2004
2004
Formation of mitoxantrone adducts in human tumor cells: potentiation by AN-9 and DNA methylation.
B. Parker
,
A. Rephaeli
,
A. Nudelman
,
D. Phillips
,
S. Cutts
Oncology Research
2004
Corpus ID: 23491132
The ability of mitoxantrone to form DNA adducts was investigated in a series of human tumor cell lines consisting of human…
Expand
2003
2003
Mitoxantrone Mediates Demethylation and Re-Expression of Cyclin D2, Estrogen Receptor 14.3.3 Sigma In Breast Cancer Cells
B. Parker
,
S. Cutts
,
A. Nudelman
,
A. Rephaeli
,
D. Phillips
,
S. Sukumar
Cancer Biology & Therapy
2003
Corpus ID: 40653071
In addition to its action as a topoisomerase II poison, mitoxantrone is activated by formaldehyde to bind DNA, forming DNA…
Expand
2001
2001
Butyrate ( AN-9 ) with the Formaldehyde-releasing Prodrug Pivaloyloxymethyl Molecular Basis for the Synergistic Interaction of Adriamycin Updated
S. Cutts
,
A. Rephaeli
,
A. Nudelman
,
I. Hmelnitsky
,
D. Phillips
2001
Corpus ID: 18625203
The interaction of Adriamycin and pivaloyloxymethyl butyrate (AN-9) was investigated in IMR-32 neuroblastoma and MCF-7 breast…
Expand
2000
2000
Uptake of pivaloyloxymethyl butyrate into leukemic cells and its intracellular esterase-catalyzed hydrolysis
Y. Zimra
,
A. Nudelman
,
+4 authors
A. Rephaeli
Journal of Cancer Research and Clinical Oncology
2000
Corpus ID: 2263868
Abstract Pivaloyloxymethyl butyrate (AN-9), a butyric acid (BA) prodrug, exhibited low toxicity and significant anticancer…
Expand
1996
1996
Esterase inhibitors diminish the modulation of gene expression by butyric acid derivative, pivaloyloxymethyl butyrate (AN-9).
E. Rabizadeh
,
M. Shaklai
,
L. Eisenbach
,
A. Nudelman
,
A. Rephaeli
Israel journal of medical sciences
1996
Corpus ID: 39942401
Pivaloyloxymethyl butyrate (AN-9) belongs to the family of acyloxyalkyl ester prodrugs of carboxylic acids which undergo…
Expand
1994
1994
Butyrate-induced differentiation in leukemic myeloid cells - in-vitro and in-vivo studies.
A. Rephaeli
,
J. Nordenberg
,
+5 authors
M. Shaklai
International Journal of Oncology
1994
Corpus ID: 21871765
A study of the effects of three differentiating agents, butyric acid, retinoic acid and cytosine arabinoside on proliferation and…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE